Clover Health Investments, Corp.

Symbol: CLOV

NASDAQ

0.737

USD

Market price today

  • -2.6255

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 362.87M

    MRK Cap

  • 0.00%

    DIV Yield

Clover Health Investments, Corp. (CLOV) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.26%

Operating Profit Margin

-0.09%

Net Profit Margin

-0.09%

Return on Assets

0.00%

Return on Equity

-0.52%

Return on Capital Employed

0.45%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Healthcare Plans
CEO:Mr. Andrew Toy
Full-time employees:552
City:Franklin
Address:725 Cool Springs Blvd
IPO:2020-06-12
CIK:0001801170

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

General Outlook

When we look at how much money they make before expenses, they keep 0.262% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.086%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.087%. This tells us they're good at keeping money after all costs.

Return on Investments

Clover Health Investments, Corp.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.520%. Furthermore, the proficiency of Clover Health Investments, Corp. in capital utilization is underscored by a remarkable 0.445% return on capital employed.

Stock Prices

Clover Health Investments, Corp.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.655, while its low point bottomed out at $0.6251. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Clover Health Investments, Corp.'s stock market.

Profitability Ratios

CLOV profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -8.65% underscores its earnings before tax deductions. The effective tax rate stands at 41.05%, revealing its tax efficiency. The net income per EBT, 100.00%, and the EBT per EBIT, 100.81%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -8.58%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-8.65%
Effective Tax Rate41.05%
Net Income per EBT100.00%
EBT per EBIT100.81%
EBIT per Revenue-8.58%

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.35, and free cash flow per share, -0.35, depict cash generation on a per-share basis. Lastly, the operating cash flow sales ratio, -0.09, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-0.35
Free Cash Flow per Share-0.35
Operating Cash Flow Sales Ratio-0.09
Free Cash Flow to Operating Cash Flow Ratio1.00
Cash Flow Coverage Ratio-38.93
Short Term Coverage Ratio-104.11
Capital Expenditure Coverage Ratio-217.18
Dividend Paid and Capex Coverage Ratio-217.18

Debt and Leverage Ratios

With a debt-equity ratio of 0.01, we discern the balance between debt and equity financing. The long-term debt to capitalization, 0.92%, and total debt to capitalization, 1.46%, ratios shed light on its capital structure. An interest coverage of -22662.71 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Equity Ratio0.01
Long Term Debt to Capitalization0.92%
Total Debt to Capitalization1.46%
Interest Coverage-22662.71
Cash Flow to Debt Ratio-38.93

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 4.21, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.44, reflects the portion of profit attributed to each share. The book value per share, 0.59, represents the net asset value distributed per share, while the tangible book value per share, 0.59, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share4.21
Net Income Per Share-0.44
Book Value Per Share0.59
Tangible Book Value Per Share0.59
Shareholders Equity Per Share0.59
Interest Debt Per Share0.01

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -41.64%, indicates top-line expansion, while the gross profit growth, 7693.05%, reveals profitability trends. EBIT growth, 43.78%, and operating income growth, 43.78%, offer insights into operational profitability progression. The net income growth, 30.14%, showcases bottom-line expansion, and the EPS growth, 31.25%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-41.64%
Gross Profit Growth7693.05%
EBIT Growth43.78%
Operating Income Growth43.78%
Net Income Growth30.14%
EPS Growth31.25%
EPS Diluted Growth31.25%
Weighted Average Shares Growth1.25%
Weighted Average Shares Diluted Growth1.25%
Operating Cash Flow Growth30.89%
Free Cash Flow Growth32.09%
10-Year Revenue Growth per Share268.15%
5-Year Revenue Growth per Share268.15%
3-Year Revenue Growth per Share152.91%
10-Year Operating CF Growth per Share26.06%
5-Year Operating CF Growth per Share26.06%
3-Year Operating CF Growth per Share-5207.78%
10-Year Net Income Growth per Share55.57%
5-Year Net Income Growth per Share55.57%
3-Year Net Income Growth per Share-20.36%
10-Year Shareholders Equity Growth per Share1362599.14%
5-Year Shareholders Equity Growth per Share1362599.14%
3-Year Shareholders Equity Growth per Share142.26%
3-Year Dividend per Share Growth per Share-100.00%
Receivables Growth-96.63%
Inventory Growth100.00%
Asset Growth-60.90%
Book Value per Share Growth-18.65%
Debt Growth-93.86%
SGA Expenses Growth-61.46%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 340,879,890.517, captures the company's total value, considering both debt and equity. Income quality, 0.54, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 0.52%, indicates the value of non-physical assets, and capex to operating cash flow, 0.50%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value340,879,890.517
Income Quality0.54
Sales General and Administrative to Revenue0.22
Intangibles to Total Assets0.52%
Capex to Operating Cash Flow0.50%
Capex to Revenue-0.03%
Capex to Depreciation-23.28%
Stock-Based Compensation to Revenue6.95%
Graham Number2.43
Return on Tangible Assets-37.58%
Graham Net Net0.16
Working Capital166,855,000
Tangible Asset Value283,404,000
Net Current Asset Value143,693,000
Average Receivables130,495,000
Average Payables34,814,500
Average Inventory-15,917,500
Days Sales Outstanding20
Days Payables Outstanding8
Days of Inventory On Hand14
ROIC-1.62%
ROE-0.74%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.44, and the price to book ratio, 1.44, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.23, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -2.51, and price to operating cash flows, -2.49, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio1.44
Price to Book Ratio1.44
Price to Sales Ratio0.23
Price Cash Flow Ratio-2.49
Enterprise Value Multiple-3.20
Price Fair Value1.44
Price to Operating Cash Flow Ratio-2.49
Price to Free Cash Flows Ratio-2.51
Price to Tangible Book Ratio1.60
Enterprise Value to Sales0.17
Enterprise Value Over EBITDA-1.89
EV to Operating Cash Flow-2.94
Earnings Yield-46.48%
Free Cash Flow Yield-25.37%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Clover Health Investments, Corp. (CLOV) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -2.626 in 2024.

What is the ticker symbol of Clover Health Investments, Corp. stock?

The ticker symbol of Clover Health Investments, Corp. stock is CLOV.

What is company IPO date?

IPO date of Clover Health Investments, Corp. is 2020-06-12.

What is company current share price?

Current share price is 0.737 USD.

What is stock market cap today?

The market cap of stock today is 362874849.000.

What is PEG ratio in 2024?

The current 0.000 is 0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 552.